The global DNA synthesizer market size was valued at USD 386.8 million in 2025 and is projected to grow from USD 419.7 million in 2026 to USD 748.2 million by 2033, at a CAGR of 8.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.5% in 2025. The increasing demand for efficient DNA synthesizers from life science laboratories, and pharmaceutical & biotechnology companies is the major factor driving the market. In addition, advancements in genomics and life sciences, coupled with an increase in the importance of DNA synthesizers in synthetic and molecular biology, are other factors supporting market expansion. Rising demand for novel synthesis technologies and technological advancements are the major factors driving the global market.
Improvements in nucleic acid synthesis methods have opened new avenues for market participants. For instance, the SYNTAX STX-100 system developed by DNA Script is the first DNA printer powered by enzymatic synthesis, enabling on-demand synthesis of custom oligos in a benchtop solution. Moreover, such synthesizers are equipped with enhanced speed and flexibility modules that enable technicians to create custom oligos in less time.
Increasing demand for benchtop DNA synthesizers, owing to their ability to increase speed & efficiency of research in academic and industrial labs, is projected contribute to market growth. Thus, the rise in demand for benchtop solutions is pushing manufacturers to develop reliable benchtop systems. For instance, in January 2025, Aldevron introduced Alchemy Cell-Free DNA Technology, the newest generation enzymatic DNA manufacturing platform for the production of linear DNA templates used for IVT and mRNA synthesis. With over 50% less time to manufacture the DNA and high purity of the DNA templates, it is expected to facilitate the workflow for genomic medicine, synthetic biology, and molecular biology applications.
The DNA synthesizer market is witnessing substantial growth due to the increasing adoption of synthetic biology, genomics research, and molecular diagnostics across the healthcare and life sciences sectors. DNA synthesizers are an important instrument to synthesize short DNA sequences for use in gene editing, genetic engineering, drug development, and vaccine creation, as well as modern biological research. The emphasis on precise medicine and personalized therapeutics has augmented the demand for efficient and correct DNA synthesis technology. Increasing investment in biotechnology research, the wide range of applications of genomics, and the development of automation systems have encouraged labs to use high-throughput DNA synthesis platforms. Increasing research processes around the world are expected to increase the market growth of reliable DNA synthesizers through the prediction period.
The increasing adoption of synthetic biology, genomics, and genetic engineering technologies is a major factor driving the growth of the DNA synthesizer market. DNA synthesizers are key devices that enable the synthesis of synthetic oligonucleotides, genes, and nucleic acid sequences, which are indispensable for molecular biology research, drug discovery, diagnostics, and biotechnology applications. The explosive growth of next-generation sequencing (NGS), CRISPR gene editing, personalized medicine, and mRNA therapeutics has also resulted in a surge in the need for high-throughput and accurate DNA synthesis platforms. In addition, the increasing investments from government organizations, research institutes, and biotechnology companies in genome research and synthetic biology programs are driving the use of high-performance DNA synthesizers. The growing need for rapid and cost-effective nucleic acid production is expected to further accelerate market growth.
▪ Canada
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ China
▪ India
▪ Australia
▪ Thailand
▪ South Korea
▪ Mexico
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Improvements in nucleic acid synthesis methods have opened new avenues for market participants. For instance, the SYNTAX STX-100 system developed by DNA Script is the first DNA printer powered by enzymatic synthesis, enabling on-demand synthesis of custom oligos in a benchtop solution. Moreover, such synthesizers are equipped with enhanced speed and flexibility modules that enable technicians to create custom oligos in less time.
Increasing demand for benchtop DNA synthesizers, owing to their ability to increase speed & efficiency of research in academic and industrial labs, is projected contribute to market growth. Thus, the rise in demand for benchtop solutions is pushing manufacturers to develop reliable benchtop systems. For instance, in January 2025, Aldevron introduced Alchemy Cell-Free DNA Technology, the newest generation enzymatic DNA manufacturing platform for the production of linear DNA templates used for IVT and mRNA synthesis. With over 50% less time to manufacture the DNA and high purity of the DNA templates, it is expected to facilitate the workflow for genomic medicine, synthetic biology, and molecular biology applications.
The DNA synthesizer market is witnessing substantial growth due to the increasing adoption of synthetic biology, genomics research, and molecular diagnostics across the healthcare and life sciences sectors. DNA synthesizers are an important instrument to synthesize short DNA sequences for use in gene editing, genetic engineering, drug development, and vaccine creation, as well as modern biological research. The emphasis on precise medicine and personalized therapeutics has augmented the demand for efficient and correct DNA synthesis technology. Increasing investment in biotechnology research, the wide range of applications of genomics, and the development of automation systems have encouraged labs to use high-throughput DNA synthesis platforms. Increasing research processes around the world are expected to increase the market growth of reliable DNA synthesizers through the prediction period.
The increasing adoption of synthetic biology, genomics, and genetic engineering technologies is a major factor driving the growth of the DNA synthesizer market. DNA synthesizers are key devices that enable the synthesis of synthetic oligonucleotides, genes, and nucleic acid sequences, which are indispensable for molecular biology research, drug discovery, diagnostics, and biotechnology applications. The explosive growth of next-generation sequencing (NGS), CRISPR gene editing, personalized medicine, and mRNA therapeutics has also resulted in a surge in the need for high-throughput and accurate DNA synthesis platforms. In addition, the increasing investments from government organizations, research institutes, and biotechnology companies in genome research and synthetic biology programs are driving the use of high-performance DNA synthesizers. The growing need for rapid and cost-effective nucleic acid production is expected to further accelerate market growth.
Global DNA Synthesizer Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global DNA Synthesizer Market report based on type, application, end-use, and region:Type Scope Outlook (Revenue, USD Million, 2021 - 2033)
- Benchtop DNA Synthesizers
- Large-scale DNA Synthesizers
Application Scope Outlook (Revenue, USD Million, 2021 - 2033)
- Drug Discovery & Development
- Genetic Engineering
- Clinical Diagnostics
End-use Scope Outlook (Revenue, USD Million, 2021 - 2033)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Clinical Laboratories
Regional Scope Outlook (Revenue, USD Million, 2021 - 2033)
- North America
▪ Canada
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ Australia
▪ Thailand
▪ South Korea
- Latin America
▪ Mexico
▪ Argentina
- Middle East & Africa
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Type Business Analysis
Chapter 5. Application Business Analysis
Chapter 6. End Use Business Analysis
Chapter 7. DNA Synthesizer Market: Regional Estimates and Trend Analysis, Type, Application, and End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Danaher
- Twist Bioscience
- Kilobaser
- LGC Limited
- CSBio
- K&A Labs GmbH
- DNA Script
- OligoMaker ApS
- PolyGen GmbH
- Biolytic Lab Performance Inc.
